TY - CHAP M1 - Book, Section TI - Chronic Myeloid Leukemia A1 - Damon, Lloyd E. A1 - Andreadis, Charalambos Babis A2 - Papadakis, Maxine A. A2 - McPhee, Stephen J. A2 - Rabow, Michael W. Y1 - 2021 N1 - T2 - Current Medical Diagnosis & Treatment 2021 AB - Key Clinical Updates in Chronic Myeloid LeukemiaIn patients with chronic myeloid leukemia who have not responded to treatment with multiple tyrosine kinase inhibitors, the novel allosteric inhibitor asciminib can be tried. It has shown a 54% complete hematologic response rate and a 48% sustained major molecular response in heavily pretreated patients. SN - PB - McGraw-Hill Education CY - New York, NY Y2 - 2023/02/07 UR - accessmedicine.mhmedical.com/content.aspx?aid=1175800568 ER -